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A B S T R A C T
Background: The annual Hajj to the Kingdom of Saudi Arabia attracts millions of pilgrims from around the
world. International health community's attention goes towards this mass gathering and the possibility of the
development of any respiratory tract infections due to the high risk of acquisition of respiratory viruses.
Method: We searched MEDLINE/PubMed and Scopus databases for relevant papers describing the prevalence of
respiratory viruses among Hajj pilgrims.
Results: The retrieved articles were summarized based on the methodology of testing for these viruses. A total of
31 studies were included in the quantitative/qualitative analyses. The main methods used for the diagnosis of
most common respiratory viruses were polymerase chain reaction (PCR), culture and enzyme-linked im-
munosorbent assay (ELISA). Influenza, rhinovirus and parainfluenza were the most common viruses detected
among pilgrims. Coronaviruses other than MERS-CoV were also detected among pilgrims. The acquisition of
MERS-CoV remains very limited and systematic screening of pilgrims showed no infections.
Conclusions: Well conducted multinational follow-up studies using the same methodology of testing are neces-
sary for accurate surveillance of respiratory viral infections among Hajj pilgrims. Post-Hajj cohort studies would
further evaluate the impact of the Hajj on the acquisition of respiratory viruses.
1. Introduction
Religious events and festivals are types of mass gathering that draw
large numbers of pilgrims from a large geographical region and people
around the globe [1,2]. The annual Hajj pilgrimage to Makkah in the
Kingdom of Saudi Arabia (KSA) attracts more than 2 million pilgrims
from 184 countries around the world [1]. The climatic conditions and
the inevitable overcrowding of pilgrims in Makkah and surrounding
holy sites during the Hajj rituals create a situation that may promote the
occurrence and spread of communicable diseases and possibly the
spread of multi-drug resistance (MDR) bacteria [1,3–9]. Thus, the
spread of respiratory illnesses during the Hajj is a major public health
concerns with the potential of dissemination of these infectious diseases
beyond the Hajj itself [10–12]. Risk factors for such an event to occur
include close proximity between pilgrims, crowded accommodation,
and congregation [1,6]. Studies had shown that respiratory tract
infections occur commonly among the majority of pilgrims [10,13].
Also, it is estimated that more than 90% of pilgrims develop what is
known as the “Hajj cough” during their stay in KSA [14–16]. Many
studies showed that a variety of upper and lower respiratory tract in-
fections due to viral and bacterial infections can cause infections among
pilgrims [3–5,10,17–21]. A range of respiratory viruses were recovered
from pilgrims, with influenza and rhinovirus the most common [10]. In
this review, we summarize the available data about emerging re-
spiratory viruses, including Middle East Respiratory Syndrome Cor-
onavirus (MERS-CoV), Severe Acute Respiratory Syndrome (SARS), and
other respiratory viruses such as influenza. We also discuss here the
possible role of Streptococcus pneumoniae coinfection.
2. Search strategy
We searched MEDLINE and Scopus databases for articles published
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in English using the following search strategy:
#1: “hadj” OR “hajj” OR “pilgrimage”;
#2: “respiratory”;
#3: “viral” OR “virus” OR “viruses” OR “pathogens” OR “infection”
OR “infections”;
#4: “influenza”;
#5: “Middle East Respiratory Syndrome Coronavirus” OR “MERS-
CoV”;
#6: “Severe Acute Respiratory Syndrome” OR “SARS”;
#7: “Pandemic H1N1”;
#8: #1 AND #2 AND #3 AND #4 AND #5 AND #6 AND #7.
We also hand searched the Saudi Epidemiology Bulletin (available
at: http://www.fetp.edu.sa/Bulletin.html) for additional articles for
inclusion.
The search results were surveyed for methodological articles, and
their titles and abstracts were then scanned. Additional studies were
identified through bibliographies of original articles or relevant re-
views. The search was done according to the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [22].
One author (JAT) performed the searches, screened titles/abstracts for
eligibility, selected relevant papers and reviewed each of the selected
manuscripts in full. All authors were in agreement regarding the choice
of papers.
3. Results
3.1. Included studies
The search strategy initially yielded 365 records of which 71 were
duplicates. Twenty additional papers were identified through hand
searching. Of the 104 full text articles reviewed, 31 studies were
included in the final analysis. The results of the search strategy are
shown in Fig. 1 according to the PRISMA methodology [22].
3.2. Types of included studies
The included studies were classified based on the methods used to
detect respiratory viruses. Methods include polymerase chain reaction
(PCR) [15,23–42] (Table 1), cell culture [26,27,43–45] (Table 2), direct
immunofluorescence staining [46], and enzyme-linked immunosorbent
assay (ELISA) [47–49] (Table 3).
3.3. Study designs
The included studies were cross-sectional studies, case-control stu-
dies, and prospective cohort studies. These studies had different designs
and methodology, and varied widely in terms of the number of included
pilgrims. We included studies addressing the prevalence of viral re-
spiratory infections. Many of these studies reported the prevalence of
clinical respiratory tract infections among pilgrims, including upper
respiratory tract infection (URTI), acute respiratory infection (ARI) or
influenza-like illness (ILI) [16,28,38,40,50–53]. We included in the
analysis studies addressing microbiology and laboratory diagnosis of
viral respiratory infections based on culture, ELISA or PCR methods.
3.4. Studies based on polymerase chain reaction methods
Included studies that used PCR methods for the detection of the
respiratory viruses are summarized in Table 1 [15,23–42,54]. The
overall analysis of these studies shows the most common viruses de-
tected among pilgrims (Fig. 2), including influenza (A and B) virus
(7.1%), influenza A (5.1%), rhinovirus (5.1%), and influenza B (1.9%).
Fig. 1. Flow diagram of the search strategy.
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These studies did not screen for the same surveyed viruses and there
was a large variation in the screened viruses (see Fig. 2).
3.5. Studies based on culture methods
A number of studies have detected respiratory viruses among pil-
grims using culture methods (Table 2). These studies included a total of
1866 pilgrims, and the most common viruses detected among them are
shown in Fig. 3.
3.6. Other studies using alternative methods for the detection of respiratory
viruses
Other studies, using alternative methods for the detection of re-
spiratory viruses, have detected respiratory viruses (primarily influenza
viruses) among pilgrims. ELISA was used in three studies [47–49] and
direct immunofluorescence staining was used in one study [46]. A
summary of the findings of these studies are presented in Table 3.
3.7. 2009 pandemic influenza A (H1N1) and the Hajj
It was feared that the 2009 pandemic influenza A (H1N1) would
result in a significant impact on the Hajj [55,56], especially that
200,000 pilgrims in 2008 were from resource-limited countries [56]. In
total, six studies investigated the prevalence of H1N1 virus among
pilgrims [27,32–34,36] and one study was conducted among healthcare
workers at the pilgrimage sites [57] (Table 4). During the 2009 Hajj
season, the prevalence of H1N1 virus among 275 symptomatic Iranian
pilgrims was 1.8% [27]. However, none of the 184 screened healthcare
workers was infected [57]. A large cross sectional study of 2699 de-
parting pilgrims showed that 0.1% of them were positive for H1N1
virus [34]. Two other studies have also founded prevalence of 1.6%
[33] and 1.8% [27], but none of the 551 Egyptian pilgrims survived in
another study were positive for H1N1 virus [32].
3.8. Threat of emerging coronaviruses
In the last decade, two coronaviruses emerged, the SARS-CoV in
2003 and the MERS-CoV in 2012. Coronavirus infections were detected
in 0.6–0.8% of tested population in regard to the Hajj seasons [3].
There were no cases of SARS linked to the Hajj [58].
3.8.1. Systematic screening for MERS-CoV among attendees of the annual
Hajj
Despite the 2012 Hajj season started few weeks after the first case of
MERS-CoV infection was reported, there were no reported cases among
pilgrims in 2012 [5,25,32]. Systematic screening of pilgrims for MERS-
CoV was done in multiple studies among> 10,000 pilgrims
[5,14,29,31,35,37–39,41,42,54,59–63] (Table 5).
3.9. Coinfection of respiratory viruses and S. pneumoniae
In a recent study conducted among 129 French pilgrims in 2013,
about 39% of those who tested positive for S. pneumoniae after the Hajj
pilgrimage were co-infected with at least one virus [38]. However,
there is no information on whether the pilgrims were carrying S.
pneumoniae or were ill secondary to this organism.
4. Discussion
The most common viruses were rhinovirus, influenza A and cor-
onavirus 229E. In addition, the acquisition of MERS-CoV remains very
limited and systematic screening of pilgrims showed no infections.
MERS-CoV is absent in all Hajj pilgrims tested so far. Different methods
were used for the diagnosis of respiratory pathogens and included: PCR,
culture methods and ELISA. The ease and rapidity of PCR method makeTa
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this method an attractive method for further use in subsequent studies
to detect respiratory viruses. Interestingly, it appears that some viruses
are more prone to transmission during Hajj (influenza and
Rhinoviruses). The difference in the transmission could be related to a
predominant aerial transmission for Influenza and Rhinoviruses
whereas other (less prevalent) could rely on direct contact (hands carry-
over). Camels were not allowed in the Hajj areas due to the risk of
MERS-CoV transmission and this strategy may further decrease the risk
of MERS-CoV transmission. Different respiratory viruses might be ac-
quired during the Hajj and these viruses might be introduced into pil-
grims' home countries upon their return, thus contributing to the po-
tential for international spread of these viruses.
Preventing influenza transmission during Hajj is an important target
for public health. Influenza vaccination should be a priority for all Hajj
pilgrims [64]. Vaccination is not so easy due to regulation on seasonal
vaccine availability [65]. In addition, non-pharmacological preventive
measures are needed for the prevention of respiratory infections during
the Hajj: maintaining good infection control practice among healthcare
Table 2
A Summary of Studies addressing the Prevalence of Respiratory Viruses among Pilgrims using Cell Culture, data presented as percentage of the total number of
included pilgrims in each study.
Reference [43] [44] [49] [26] [27]
Study Design Cross-sectional study
(Saudi Arabia)
Cross-sectional study
(Saudi Arabia)
Cross-sectional study
(Saudi Arabia)
Cross-sectional airport
study (Iran)
Cross-sectional airport
study (Iran)
Number of Included Pilgrims 761 500 105 225 275
Influenza A 4.5 0.6 1.9 5.1
H1N1 1.1
Influenza B 2 5.4 11.4 5.1
Influenza overall 6.5 6 13.3 5.1 1.1
Parainfluenza 1 2
Parainfluenza 2 1.7
Parainfluenza 3 2.2
Parainfluenza overall 5.9 0.8 0
Adenovirus 4.7 0 36.2
Respiratory syncytial virus 2.4 1.4 1.9
Herpes virus 2.6
Table 3
A Summary of Studies addressing the Prevalence of Respiratory Viruses among
Pilgrims using Direct Immunofluorescence Staining or ELISA, data presented as
percentage of the total number of included pilgrims in each study.
Reference [46] [47] [48] [49]
Methodology Direct immunofluorescence
staining
ELISA ELISA ELISA
Year 1994 2000 2004 2004–5
Number of Included
Pilgrims
64 305 360 105
Influenza A 3.1 5.9
H1N1 6.9
H3N2 6.1
Influenza B 1.6 11.5 20.8
Influenza overall 4.7 17.4 12.8
Parainfluenza 1 0
Parainfluenza 2 1.6
Parainfluenza 3 0
Parainfluenza overall 1.6
Fig. 2. A summary of studies among pilgrims showing the most common respiratory viruses using PCR based techniques.
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workers, the use of face masks or respirators, and hand hygiene
[66,67]. The majority of viral respiratory infections acquired during
pilgrimage are due to influenza viruses, and rhinoviruses [64]. The
diagnosis of seasonal influenza during the hajj was a major focus of
most studies addressing the prevalence of respiratory viruses among
pilgrims [23,25,32–34,36,39,40,43,56,68–80]. In these studies, dif-
ferent methods were used to detect respiratory viruses, with PCR being
the most common used method. There are multiple contributing factors
for the transmission and acquisition of respiratory viruses during the
Hajj and include the crowdedness, close proximity, and indoor or out-
door venue [80].
Consistent with few studies worldwide, entero-rhinovirus was the
most common virus isolated among pilgrims. However, this result is
related to a single study of 2699 departing pilgrims that showed a 13%
acquisition rate [34]. It was shown that entero-rhinovirus the primary
cause of common colds [81,82].
With the emergence of the pandemic 2009 H1N1, there was a fear of
the significant impact on the Hajj [55,56]. However, different studies
showed very low rate of acquisition of this virus during the 2009 Hajj.
Also, the emergence of SARS-CoV and MERS-CoV was of major con-
cerns for mass gatherings such as the Hajj [2,5]. However, to date
neither SARS-CoV nor MERS-CoV was found to be transmitted among
pilgrims. Systematic screening for MERS-COV among returning or de-
parting pilgrims showed no positive cases
[5,14,15,29–31,35,37–39,60,61,63]. However, four cases were linked
to Umrah (also known as the lesser pilgrimage) [69,83–86]. It was es-
timated that the risk MERS-CoV transmission among pilgrims could be
1–7 cases per Hajj season and 3–10 per Umrah per year [87].
Various studies showed different acquisition rates of respiratory
viruses, but only one study showed coinfection with S. pneumoniae.
Recent studies showed a significant acquisition of S. pneumoniae and
Hemophilus influenzae by returning pilgrims [3,10,12,66,88].
Viral respiratory tract infections, mainly rhinovirus, influenza A and
coronavirus 229E, are of major concern during the Hajj. Despite ex-
tensive systematic screening, MERS-CoV had not been isolated from
pilgrims. Continued surveillance for MERS-CoV is needed to ensure
timely detection of any possible imported MERS cases [8,9,64]. Dif-
ferential transmission of different viruses may play a role in the ob-
served frequencies. Understanding these factors facilitate the develop-
ment of preventive measures. Further paired prospective studies using a
systematic evaluation of pilgrims for these viruses are needed in order
to estimate the total burden of viral respiratory diseases during the Hajj.
International collaboration would foster evidence-based practices and
guidelines for implementation during mass gathering events [10].
Fig. 3. A Summary of Studies among Pilgrims Showing the Most Common Respiratory Viruses Using Culture based Methods.
Table 4
A Summary of Studies addressing the Prevalence of Pandemic H1N1 Influenza
among Pilgrims.
Reference Study Design Population Number
Tested
n (%)
Positive
[27] cross
sectional
Returning Iranian
pilgrims
275 5 (1.8)
[32] cross
sectional
Returning Egyptian
pilgrims
551 0 (0)
[33] cross
sectional
Returning Iranian
pilgrims
305 5 (1.6)
[34] cross
sectional
Departing pilgrims 2699 2 (0.1)
[36] cross
sectional
Pilgrims 1600 9 (0.5)
[57] cross
sectional
Healthcare workers 184 0 (0)
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